Literature DB >> 7540656

Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.

J A Boyce1, D Friend, R Matsumoto, K F Austen, W F Owen.   

Abstract

Granulocytes with the hybrid characteristics of eosinophils and basophils have been identified in the bone marrow and peripheral blood of humans with myeloid leukemias. We now describe a technique by which such hybrid granulocytes can be developed in vitro from normal cord blood precursors cultured in the presence of recombinant human interleukin (rhIL) 3 (350 pM) and rhIL-5 (200 pM) in a plastic vessel coated with Matrigel. After 14 d in culture, 90 +/- 3% (mean +/- standard error of the mean) of the nonadherent cells cultured in the Matrigel-coated flasks contained both eosinophil and basophil granules, as indicated by staining with Wright's and Giemsa stains. Of the nonadherent cells, 93 +/- 1% contained cyanide-resistant peroxidase, and 88 +/- 2% were toluidine blue-positive, characteristic of eosinophil and basophil granules, respectively. Transmission electron micrographs showed hybrid cells containing ultrastructurally distinct eosinophil granules with developing crystalline cores and basophil granules with reticular structures. These 14-d cord blood-derived cell cultures showed strong hybridization signals for eosinophil-derived neurotoxin by RNA blot analysis and contained 78 ng histamine per 10(6) cells. When the granulocytes were removed from cytokine-containing medium and suspended without Matrigel in RPMI 1640 medium containing 10% fetal calf serum (FCS), more than 80% of the granulocytes excluded trypan blue for as long as 5 d, and 93% had developed into eosinophils at 6 d. Conditioned medium prepared over 48 h from the 14-d cell cultures (hybrid granulocytes) sustained the 4-d viability in vitro of 78% of peripheral blood eosinophils from atopic donors. In comparison, 13% survived in RPMI 1640 containing 10% FCS alone. This viability-sustaining activity was nearly completely neutralized by an anti-granulocyte/macrophage colony-stimulating factor (GM-CSF) antibody and was only minimally reduced by anti-IL-3 or IL-5. Thus, cells possessing both eosinophil and basophil granules by both histochemical and ultrastructural analysis can be developed from normal progenitors in vitro in response to eosinophilopoietic cytokines and Matrigel. Their subsequent spontaneous development into mature eosinophils suggests that hybrid granulocytes are part of a normal developmental sequence during eosinophilopoiesis. Furthermore, these hybrid granulocytes are capable of autoregulation through elaboration of GM-CSF, which sustains their viability.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540656      PMCID: PMC2192091          DOI: 10.1084/jem.182.1.49

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

Review 1.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

2.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.

Authors:  T T Hansel; I J De Vries; T Iff; S Rihs; M Wandzilak; S Betz; K Blaser; C Walker
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis.

Authors:  I Ohno; R Lea; S Finotto; J Marshall; J Denburg; J Dolovich; J Gauldie; M Jordana
Journal:  Am J Respir Cell Mol Biol       Date:  1991-12       Impact factor: 6.914

4.  Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.

Authors:  A F Lopez; M A Vadas; J M Woodcock; S E Milton; A Lewis; M J Elliott; D Gillis; R Ireland; E Olwell; L S Park
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

5.  Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.

Authors:  D H Broide; M M Paine; G S Firestein
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.

Authors:  E Her; J Frazer; K F Austen; W F Owen
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions.

Authors:  D A Williams; M Rios; C Stephens; V P Patel
Journal:  Nature       Date:  1991-08-01       Impact factor: 49.962

8.  Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation.

Authors:  T Tsuda; D Wong; J Dolovich; J Bienenstock; J Marshall; J A Denburg
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

9.  The major laminin receptor of mouse embryonic stem cells is a novel isoform of the alpha 6 beta 1 integrin.

Authors:  H M Cooper; R N Tamura; V Quaranta
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

10.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.

Authors:  R Moqbel; Q Hamid; S Ying; J Barkans; A Hartnell; A Tsicopoulos; A J Wardlaw; A B Kay
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  26 in total

1.  IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production.

Authors:  H Ochi; N H De Jesus; F H Hsieh; K F Austen; J A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell.

Authors:  Egle Passante; Neil Frankish
Journal:  Inflamm Res       Date:  2009-08-09       Impact factor: 4.575

3.  The clinical significance of eosinophils in the amniotic fluid in preterm labor.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Ricardo Gomez; Ronald Lamont; Egle Bytautiene; Robert E Garfield; Pooja Mittal; Sonia S Hassan; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

4.  Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.

Authors:  John W Steinke; Lixia Liu; Phillip Huyett; Julie Negri; Spencer C Payne; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-06-24       Impact factor: 10.793

5.  Eotaxin is required for the baseline level of tissue eosinophils.

Authors:  A N Matthews; D S Friend; N Zimmermann; M N Sarafi; A D Luster; E Pearlman; S E Wert; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 6.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 7.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

8.  The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.

Authors:  Hiromi Iwasaki; Shin-ichi Mizuno; Yojiro Arinobu; Hidetoshi Ozawa; Yasuo Mori; Hirokazu Shigematsu; Kiyoshi Takatsu; Daniel G Tenen; Koichi Akashi
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

9.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

Review 10.  Mechanisms controlling mast cell and basophil lineage decisions.

Authors:  Hua Huang; Yapeng Li
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.